Implantable remote patient monitoring market seen reaching $27.48 billion by 2030

The implantable remote patient monitoring devices market is projected to grow from $10.26 billion in 2025 to $27.48 billion by 2030, driven by telehealth adoption, chronic disease management and sensor advances. North America held the largest share in 2025 as the market shifts toward real-time data sharing and home-based care.

Why it matters: - Implantable remote patient monitoring devices are moving care away from hospital visits and toward continuous, real-time oversight from inside the body. - The market’s expected jump to $27.48 billion by 2030 signals faster adoption of connected care tools for chronic disease management and older patients. - Telehealth integration is making implanted sensors more useful by speeding data sharing between patients and clinicians.

What happened: - The Business Research Company released its Implantable Remote Patient Monitoring Devices Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035. - The report puts market size at $10.26 billion in 2025 and $12.51 billion in 2026. - The report forecasts the market will reach $27.48 billion by 2030. - North America held the largest share of the market in 2025. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa.

The details: - Implantable remote patient monitoring devices are surgically placed in patients to track heart rhythm, blood pressure, glucose levels and other physiological signals. - Embedded sensors and wireless communication systems send data from inside the body to healthcare providers. - The technology supports early detection of health problems and can reduce the need for frequent hospital visits. - The market is expected to grow at a CAGR of 21.9% from 2025 to 2026. - The market is forecast to grow at a CAGR of 21.7% from 2026 to 2030. - The report cites growth drivers including implantable sensor advances, rising chronic illness rates, telemedicine integration, an aging population and favorable reimbursement policies. - The report highlights wider use of continuous glucose monitoring devices, implantable cardiac monitoring systems, smart weight tracking devices, remote home care monitoring and real-time data sharing. - The report notes earlier growth barriers including limited awareness, reliance on in-hospital monitoring, slow adoption of implantable technologies, weak wireless connectivity and high device costs. - The report includes market attractiveness scoring, TAM analysis, company scoring matrices, Excel dashboards, market hotspot infographics, updated graphics and tables.

Between the lines: - The market’s growth is being shaped by a broader shift in healthcare toward monitoring patients outside the hospital. - Telehealth usage appears to be reinforcing demand because remote visits make implanted devices more practical for ongoing care. - FAIR Health Inc. data showed national telehealth usage rose 7.3% in 2023, from 5.5% of medical claim lines in December 2022 to 5.9% in January 2023. - That kind of adoption suggests the market’s biggest gains may come from systems that combine sensing, connectivity and care coordination.

What's next: - The market’s next phase likely centers on broader deployment of cardiac, glucose and home-monitoring implants. - Growth will depend on continued sensor improvements, stronger telehealth links and payer support for remote monitoring. - The report points to continued expansion in real-time data sharing and patient safety features through 2030.

The bottom line: - Implantable remote patient monitoring is emerging as a fast-growing segment of connected care, with North America leading today and telehealth helping accelerate demand worldwide.